How FDA’s New Real-World Data Guidance Solves 3 Big Problems
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to grow across obesity and metabolic disease, but the way patients access these therapies is changing in ways that complicate traditional research approac...